Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21531792)

  • 1. Therapeutic effects on atopic dermatitis by anti-RelA short interfering RNA combined with functional peptides Tat and AT1002.
    Uchida T; Kanazawa T; Kawai M; Takashima Y; Okada H
    J Pharmacol Exp Ther; 2011 Aug; 338(2):443-50. PubMed ID: 21531792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002.
    Uchida T; Kanazawa T; Takashima Y; Okada H
    Chem Pharm Bull (Tokyo); 2011; 59(2):196-201. PubMed ID: 21297299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis.
    Ibaraki H; Kanazawa T; Kurano T; Oogi C; Takashima Y; Seta Y
    Biol Pharm Bull; 2019; 42(7):1216-1225. PubMed ID: 31257297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Int J Pharm; 2018 May; 542(1-2):213-220. PubMed ID: 29551748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
    Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
    Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis.
    Kanazawa T; Hamasaki T; Endo T; Tamano K; Sogabe K; Seta Y; Ohgi T; Okada H
    Int J Pharm; 2015 Jul; 489(1-2):261-7. PubMed ID: 25956048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat.
    Kigasawa K; Kajimoto K; Hama S; Saito A; Kanamura K; Kogure K
    Int J Pharm; 2010 Jan; 383(1-2):157-60. PubMed ID: 19732811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
    J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide.
    Ibaraki H; Kanazawa T; Takashima Y; Okada H; Seta Y
    Molecules; 2016 Sep; 21(10):. PubMed ID: 27669207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
    Noh SU; Cho EA; Kim HO; Park YM
    Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice.
    Kim HS; Kim DH; Kim BK; Yoon SK; Kim MH; Lee JY; Kim HO; Park YM
    Int Immunopharmacol; 2011 Feb; 11(2):280-5. PubMed ID: 21118672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice.
    Kang MJ; Eum JY; Park SH; Kang MH; Park KH; Choi SE; Lee MW; Kang KH; Oh CH; Choi YW
    Int J Pharm; 2010 Dec; 402(1-2):198-204. PubMed ID: 20888893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis.
    Tominaga M; Ozawa S; Ogawa H; Takamori K
    J Dermatol Sci; 2007 Jun; 46(3):199-210. PubMed ID: 17350228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Tagami H
    Skin Res Technol; 2004 May; 10(2):122-9. PubMed ID: 15059180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
    Horiuchi Y; Bae S; Katayama I; Nishioka K
    J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of dermatitis by iontophoretically delivered antisense oligonucleotides for interleukin-10 in NC/Nga mice.
    Sakamoto T; Miyazaki E; Aramaki Y; Arima H; Takahashi M; Kato Y; Koga M; Tsuchiya S
    Gene Ther; 2004 Feb; 11(3):317-24. PubMed ID: 14737092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
    Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
    Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of a novel ceramide derivative, K6PC-9, inhibits dust mite extract-induced atopic dermatitis-like skin lesions in NC/Nga mice.
    Kang JS; Youm JK; Jeong SK; Park BD; Yoon WK; Han MH; Lee H; Han SB; Lee K; Park SK; Lee SH; Yang KH; Moon EY; Kim HM
    Int Immunopharmacol; 2007 Dec; 7(13):1589-97. PubMed ID: 17996668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.